At a Glance
| Isopropylphenidate | 3,4-CTMP | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 15–25 mg | 4–6 mg |
| Total Duration | 2–3.7 hrs | 1–2 hrs |
| Routes | insufflatedoral | oral |
Isopropylphenidate, a Stimulants, and 3,4-CTMP, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 22 documented effects in common, with 4 effects unique to Isopropylphenidate and 22 unique to 3,4-CTMP. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Isopropylphenidate | 3,4-CTMP | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 15–25 mg | 4–6 mg |
| Total Duration | 2–3.7 hrs | 1–2 hrs |
| Routes | insufflatedoral | oral |
| Effects | 26 documented | 44 documented |
| Level | Isopropylphenidate | 3,4-CTMP |
|---|---|---|
| Threshold | 2 mg | 2 mg |
| Light | 5–15 mg | 2–4 mg |
| Common | 15–25 mg | 4–6 mg |
| Strong | 25–45 mg | 6–8 mg |
| Heavy | 45 mg | 8 mg |
| Level | Dose |
|---|---|
| Threshold | 2 mg |
| Light | 5–10 mg |
| Common | 10–20 mg |
| Strong | 20–35 mg |
| Heavy | 35 mg |
Isopropylphenidate
3,4-CTMP
No direct interaction data available between these substances. This does not mean the combination is safe.